CRISPR And Cas Gene Market Report 2026

CRISPR And Cas Gene Market Overview

• CRISPR And Cas Gene market size has reached to $4.81 billion in 2025 • Expected to grow to $13.1 billion in 2030 at a compound annual growth rate (CAGR) of 22.3% • Growth Driver: Personalized Therapy Driving Surge In CRISPR And Cas Gene Market Growth • Market Trend: CRISPR-Based Cell-Based Gene Therapy Revolutionizes Treatment Landscape In The CRISPR And Cas Gene Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under CRISPR And Cas Gene Market?

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, and the Cas (CRISPR-associated) gene, particularly Cas9, constitute a powerful gene-editing technology. This system enables precise modifications to DNA sequences, revolutionizing genetic research, biotechnology, and potential medical applications. The main product types of CRISPR and Cas genes include kits and enzymes, libraries, design tools, antibodies, and others. Kits and enzymes constitute essential components in the area of CRISPR-based gene therapy, with kits including the ingredients and instruments required for gene editing research and enzymes, such as Cas9, playing an important part in the gene editing process. The services are categorized into cell line engineering, gRNA design, microbial gene editing, and DNA synthesis and are used in applications such as clinical, financial, operational, and administrative by end users such as biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs).

What Is The CRISPR And Cas Gene Market Growth Forecast?

The crispr and cas gene market size is expected to see exponential growth in the next few years. It will grow to $13.1 billion in 2030 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to clinical translation of gene editing, expansion of personalized medicine, growth of biotech startups, increasing research investments, advancements in delivery systems. Major trends in the forecast period include expansion of gene editing research applications, growing use in cell line engineering, increased adoption in drug discovery, development of advanced crispr libraries, growth of custom gene editing services.

Global CRISPR And Cas Gene Market Segmentation

1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types 2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis 3) By Application: Clinical, Financial, Operational And Administrative 4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs) Subsegments: 1) By Kits And Enzymes: CRISPR Kits, Cas Enzymes, Grna Synthesis Kits 2) By Libraries: CRISPR Libraries For Gene Knockout, CRISPR Libraries For Gene Activation, Sgrna Libraries 3) By Design Tools: Online Design Platforms, Software For CRISPR Guide RNA Design, Custom Design Services 4) By Antibodies: Antibodies For Cas Proteins, Antibodies For Detection Of Edited Cells, Secondary Antibodies For Immunoassays 5) By Other Product Types: Delivery Systems, CRISPR-Related Consumables, Control Plasmids And Reagents

What Is The Driver Of The CRISPR And Cas Gene Market?

A growing focus on personalized therapy is expected to propel the growth of the CRISPR and Cas gene markets going forward. Personalized therapy refers to a medical model that uses an individual's genetic profile to guide decisions made concerning the diagnosis, treatment, and prevention of disease. CRISPR and the Cas gene, particularly Cas9, are used in personalized medicine, enabling precise modifications to an individual's genetic material and holding promise for breakthroughs in developing tailored therapies for genetic disorders, cancer, and various medical conditions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based organization, in 2023, the FDA granted approval to 16 novel personalized therapies designed for rare disease patients, an increase from the six such treatments approved in 2022. Therefore, the rising demand for personalized therapy will drive the growth of the CRISPR and Cas gene markets.

Key Players In The Global CRISPR And Cas Gene Market

Major companies operating in the crispr and cas gene market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc, AstraZeneca plc, Danaher Corporation, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, GenScript, Takara Bio Inc., Merck KGaA, Horizon Discovery Group Plc, Beam Therapeutics Inc, Intellia Therapeutics Inc, New England BioLabs, Recursion Pharmaceuticals Inc, Caribou Biosciences Inc, Cellectis S.A., Editas Medicine Inc, CRISPR Therapeutics AG, Mammoth Biosciences, Inscripta Inc, Prime Medicine Inc, Precision BioSciences Inc, Sangamo Therapeutics Inc.

Global CRISPR And Cas Gene Market Trends and Insights

Major companies operating in the CRISPR and Cas gene markets are developing innovative products such as CRISPR-based cell-based gene therapy to enhance product offerings and gain a competitive advantage. CRISPR-based cell-based gene therapy involves using the CRISPR gene-editing technology to modify or correct genetic material within cells, offering a targeted and potentially revolutionary approach to treating genetic disorders, diseases, and other medical conditions at the cellular level. For instance, in December 2023, Vertex Pharmaceuticals Incorporated, a US-based biopharmaceutical company, received approval for CASGEVY (exagamglogene autotemcel [exa-cel]) from the U.S. Food and Drug Administration (FDA). CASGEVY is a CRISPR/Cas9 genome-edited gene therapy for the management of sickle cell disease (SCD) in individuals aged 12 and above who have recurrent vaso-occlusive crises. CASGEVY is a first-of-its-kind medication that has the potential to be a one-time transformational therapy for qualified sickle cell patients. CASGEVY administration necessitates specific training in stem cell transplantation, hence, Vertex is collaborating with experienced institutions to create a network of independently owned, approved treatment centers (ATCs) across the United States to provide CASGEVY to patients.

What Are Latest Mergers And Acquisitions In The CRISPR And Cas Gene Market?

In July 2025, Eli Lilly and Company, a US-based pharmaceutical firm, completed the acquisition of Verve Therapeutics, Inc. for an undisclosed amount. Through this acquisition, Lilly aims to advance one-time, CRISPR-based genetic therapies designed to deliver lifelong reduction in cardiovascular risk by integrating Verve’s in vivo gene-editing platforms into its cardiometabolic pipeline. Verve Therapeutics Inc. is a US-based clinical-stage biotechnology company specializing in CRISPR-based gene-editing medicines for cardiovascular disease.

Regional Outlook

North America was the largest region in the CRISPR and Cas gene market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the CRISPR And Cas Gene Market?

The CRISPR and Cas gene market consists of revenues earned by entities by offering services such as gene editing, targeted disruption of genes, targeted drug development, livestock breeding, and animal model construction. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR and Cas gene market also includes sales of RNA clean-up kits, phenol-free kits, t7 polymerase mix, and RNAse-free water. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the CRISPR And Cas Gene Market Report 2026?

The crispr and cas gene market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the crispr and cas gene industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.